Anti-Aging-Drugs.com
   
 Unbeatable prices and quality
Call us on + 44 208-144-4719
   
Health information and news   
Subscribe
to Anti-Aging Newsletter
Email:
Diseases of Aging

Tamiflu sale!

ZYPREXA - GENERIC

Generic name: Olanzapine
Reviews
Arch Phys Med Rehabil. 2005 Mar;86(3):587-90.
Olanzapine for the treatment of hemiballismus: A case report.
Mukand JA, Fitzsimmons C, Wennemer HK, Carrillo A, Cai C, Bailey KM.
Mukand JA, Fitzsimmons C, Wennemer HK, Carrillo A, Cai C, Bailey KM.

Olanzapine for the treatment of hemiballismus: a case report. Hemiballismus is a rare movement disorder characterized by involuntary, large amplitude movements of the limbs of 1 side of the body. We describe the case of a man in his late sixties with slurred speech, agitation, and right-sided hemiballismus resulting from a left thalamic hemorrhagic stroke. Treatment with haloperidol was unsuccessful, but both the hemiballismus and agitation diminished significantly after initiation of olanzapine (Zyprexa). The improvement in the hemiballismus was quantified by recording the number of hemiballistic movements that occurred while the patient performed standardized 30-minute sessions (daily for 5d). With the first task (reaching within the base of support while seated), the average number of hemiballismic movements per session decreased from a baseline of 23.5 to 3.0 in the upper extremity and from 20.5 to 7.0 in the lower extremity. With the second task (catching a ball while seated), the abnormal movements decreased from 52 to 6.3 in the upper extremity and from 34.5 to 2.7 in the lower extremity. This case suggests that olanzapine may be a valuable pharmacologic alternative for patients with hemiballismus.

Am J Health Syst Pharm. 2005 Mar 15;62(6):610-5.
Health care costs for schizophrenia patients started on olanzapine versus risperidone.
Russo PA, Smith MW, Namjoshi M.
Outcomes Research and Econometrics, The Medstat Group, Washington, DC.

PURPOSE: The change in direct medical costs for schizophrenia patients who were started on olanzapine or risperidone and who were privately insured was studied. METHODS: A retrospective analysis of 1996-1999 data from the databases representing the health care experiences of individuals employed by large organizations and their dependents was performed. The sample included all individuals with a drug claim for olanzapine or risperidone, a claim with a schizophrenia diagnosis within 90 days of the drug claim, no claim for the same drug in the prior six months, and continuous health-plan enrollment for 12 months before and after the prescription. RESULTS: The sample included 162 patients initiated on olanzapine and 119 patients initiated on risperidone. Demographic and clinical profiles were not significantly different between groups. Annual schizophrenia-related prescription and outpatient costs increased following initiation on olanzapine or risperidone compared with the preinitiation period. This was partially offset by a decrease in inpatient expenditures. Olanzapine initiators had higher outpatient drug expenditures than risperidone initiators in the 12 months following initiation (adjusted means, $2105 versus $1934) (p < 0.05), but there was no significant difference between groups in total schizophrenia-related payments ($5251 versus $4950). CONCLUSION: The total health care expenditure related to treating schizophrenia was similar between privately insured patients who were initiated on olanzapine and patients who were started on risperidone.
Return to Top
Drug information

GENERIC NAME: olanzapine
BRAND NAME: Zyprexa


DRUG CLASS AND MECHANISM: Olanzapine is a medication that is used to treat psychoses including schizophrenia and acute manic episodes associated with bipolar I disorder. Olanzapine is similar in chemical structure and in mechanism of action to clozapine (Clozaril). Like clozapine, olanzapine works by blocking receptors on the nerves of the brain for several neurotransmitters (chemicals that nerves use to communicate with each other). It binds to alpha-1, dopamine, histamine H-1, muscarinic, and serotonin type 2 (5-HT2) receptors. Olanzapine was approved by the FDA in 1996.

PREPARATIONS: Tablets of 5, 7.5, and 10 mg

STORAGE: Tablets should be kept at room temperature, 15-30°C (59-86°F).

PRESCRIBED FOR: Olanzapine is used for treating patients with schizophrenia and manic episodes associated with bipolar I disorder. It also is used as maintenance therapy for bipolar disorder.

DOSING: Olanzapine is usually given once daily, with the dose often adjusted upward until an optimal dose is found. It may be taken with or without food. Tobacco smokers may need higher doses.

DRUG INTERACTIONS: Reduced or increased blood levels: Carbamazepine (Tegretol) can significantly reduce blood concentrations of olanzapine, possibly necessitating higher doses of olanzapine. Other drugs that also may reduce blood level of olanzapine are omeprazole (Prilosec) and rifampin. Cimetidine (Tagamet), ciprofloxacin (Cipro), diltiazem (Cardizem; Dilacor; Tiazac), erythromycin, and fluvoxamine (Luvox) may have the opposite effect, that is, they may increase blood levels, and the dose of olanzapine possibly may need to be reduced.

Low blood pressure: Olanzapine can cause orthostatic hypotension, a drop in blood pressure upon rising that may cause dizziness. Taking olanzapine with either diazepam (Valium), another related benzodiazepine or ethanol can exaggerate the orthostatic hypotension caused by olanzapine.

PREGNANCY: There are no adequate studies of olanzapine in pregnant women. Some studies in animals suggest no important effects on the fetus, whereas others suggest an ill-effect. Olanzapine can be used in pregnancy if the physician feels that it is necessary.

NURSING MOTHERS: It is not known if olanzapine is secreted in breast milk in humans, but animal studies show that olanzapine is excreted into breast milk. Therefore, it is recommended that olanzapine not be used in nursing mothers.

SIDE EFFECTS: The most common side effects seen with olanzapine are akathisia (a feeling of an inability to sit still), constipation, dizziness, drowsiness, objectionable behavior, orthostatic hypotension (see DRUG INTERACTIONS), and weight gain. Each of these side effects may occur in 1 in 20 persons.

Disorders of movement: Extrapyramidal effects (sudden, often jerky, involuntary motions of the head, neck, arms, body, or eyes) may occur with use of olanzapine. Tardive dyskinesia (involuntary movements of the mouth, tongue, jaw, or eyelids) may occur in 1 in 100 patients receiving olanzapine. Some cases can be irreversible. The likelihood of developing tardive dyskinesia increases with prolonged treatment.

There may be an increased risk of increased blood sugar levels and diabetes with olanzapine as well as the other antipsychotic medications in its class. Patients should be tested during treatment for elevated blood-sugars. Additionally, persons with risk factors for diabetes, including obesity or a family history of diabetes, should have their fasting levels of blood sugar tested before starting treatment and periodically throughout treatment to detect the onset of diabetes. Any patient developing symptoms that suggest diabetes during treatment should be tested for diabetes.

Caution! Before starting to take this medicine, it is vital that you should consult your doctor! Do not use it on your own initiative, without medical advice.

Return to Top

Order now !
ZYPREXA - GENERIC (schizophrenia) (generic - what is it?)
Dosage
Packing
Price
Pay now
2.5 mg
100 tab
USD 55.00
5 mg
100 tab
USD 63.00
7.5 mg
100 tab
USD 69.00
10 mg
100 tab
USD 79.00
 

Return to Previous Page  Return to Top

 
VISA